Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 26, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Drug to treat African trypanosomiasis (sleeping sickness) disease discovered

Epilepsy is more than a tremor- World Epilepsy day 8th February.

THE BRAIN’S REWARD SYSTEM: NEUROBIOLOGY OF DRUG ADDICTION

Drug to treat African trypanosomiasis (sleeping sickness) disease discovered
  • BiotechToday
  • World

Drug to treat African trypanosomiasis (sleeping sickness) disease discovered

bioxone February 8, 2021February 7, 2021

Husna, Amity University Kolkata

African trypanosomiasis, also known as sleeping sickness is a disease fatal to both humans and animals. It is transmitted to humans and animals by the tsetse fly.

 A vaccine for protection from this disease hasn’t been discovered making its transmission control rely on eliminating the tsetse fly population. Neurotoxic insecticides and pesticides can be sprayed on insects and are very much effective for insect and pest control but they harm the environment and they also reduce populations of some beneficial insect pollinator species.

 Recently an international team of researchers has suggested an environment-friendly alternative, the drug Nitisinone (NTBC). An FDA approved drug that can eliminate tsetse flies by targeting an essential digestive pathway. The pathway is co-shared by all blood-feeding insects.  Using this drug has the additional benefit of killing other blood-sucking arthropods like mosquitoes and ticks. 

This drug is deemed to be ecologically friendly.  It has the potential of reducing the transmission of African trypanosomiasis (sleeping sickness) in sub-Saharan Africa. Unlike any insecticide, The drug posses execution capabilities for only blood-feeding insects and not sugar feeders such as pollinating insects.

Also read: Epilepsy is more than a tremor- World Epilepsy day 8th February.

SOURCE:  Sterkel M, Haines LR, Casas-Sánchez A, Owino Adung’a V, Vionette-Amaral RJ, Quek S, et al. (2021) Repurposing the orphan drug nitisinone to control the transmission of African trypanosomiasis. PLoS Biol 19(1): e3000796. Published: January 26, 2021 https://doi.org/10.1371/journal.pbio.3000796

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged african trypanosoma disease disease by mosquito disease vector environmentally friendly FDA fda approved fda drugs insecticide sprayer insecticides mosquitoes sleeping sickness trypanosoma african sleeping sickness tsetse fly

3 thoughts on “Drug to treat African trypanosomiasis (sleeping sickness) disease discovered”

  1. Pingback: THE BRAIN’S REWARD SYSTEM: NEUROBIOLOGY OF DRUG ADDICTION - BioXone
  2. Diwita says:
    February 9, 2021 at 7:21 am

    Illuminating content and beautifully written!!

    Reply
    1. Farah Noor says:
      February 14, 2021 at 1:26 pm

      Wow😍😍😍 so useful information and easy to remember!

      Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Biotechnopedia
  • DNA-Tales

THE BRAIN’S REWARD SYSTEM: NEUROBIOLOGY OF DRUG ADDICTION

bioxone February 8, 2021

Shinjini Bandopadhyay, Amity University Kolkata Addiction is defined as a chronic, relapsing disease of the brain. It is a biological process that alters the neurochemical pathways in the brain. Although addictions may be of varying types, the most frequently occurring and the most damaging ones include substance abuse (drugs, alcohol, tobacco). Substance abuse physically affects […]

REWARD SYSTEM

Related Post

  • BiotechToday
  • World

A New way to Fight Diseases?

bioxone November 17, 2020November 17, 2020

Shrayana Ghosh, Amity University Kolkata Recently a mechanism has been determined by which microRNAs can be degraded by cells. This was discovered by researchers at UT Southwestern Medical Center. The information sheds light on the working of cells and how that can be used to establish a new way to combat infectious diseases and cancer. […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Can the MMR Vaccine provide protection against COVID-19!

bioxone November 24, 2020November 24, 2020

Ayooshi Mitra, Amity University Kolkata COVID-19 has presented various contradictions that may provide clues to control the pandemic, even before a COVID-19 vaccine is widely available. A study conducted recently by a group of researchers has shown that the measles-mumps-rubella (MMR) vaccine is theoretically capable of protecting against COVID-19. Mumps IgG titers or antibody levels […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Can shingles develop without chickenpox?

bioxone August 3, 2021August 2, 2021

Sneha Singhal, Jaypee Institute of information technology, Noida What is Chickenpox? The Varicella-zoster virus (VZV) causes chickenpox, which is a highly contagious disease. It can result in a rash that is itchy and blistery. The rash begins on the chest, back, and face, then spreads across the body, leaving 250 to 500 itching blisters. It can […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy